Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Spain Financial News Hub.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on August 25, 2025
Sovereign streaming for Europe’s digital decade: G&L Systemhaus defines resilient infrastructures
EIN Presswire
·
August 25, 2025
Institutions and broadcasters gain trusted streaming workflows designed for reliable control, sustainable growth, and future-proof performance. COLOGNE, GERMANY, August 25, 2025 /EINPresswire.com/ -- G…
XS.com Gana el Premio a la “Mejor Investigación de Mercado” en Money Expo India 2025
EIN Presswire
·
August 25, 2025
COLOMBIA, August 25, 2025 /Business News/ -- XS.com, la principal firma global de FinTech y corretaje multi-activos, fue galardonada con el premio a la “Mejor Investigación de Mercado” en Money Expo India 2025, celebrado los días 23 y 24 de agosto en el …
Bybit Releases Crypto Insights Report Highlighting Key Technical Levels and Institutional Trends in Ethereum (ETH)
Chainwire
·
August 25, 2025
Dubai, UAE, August 25th, 2025, Chainwire Bybit, the world’s second-largest cryptocurrency exchange by trading volume, released its latest Crypto Insights Report on Ethereum (ETH), outlining the key levels, catalysts, and institutional trends shaping the …
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
GlobeNewswire
·
August 25, 2025
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …